XENE · Xenon Pharmaceuticals Inc. · Documents
$36.47
+1.39 (+3.96%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$3.51B
Shares
96.84M
Volume · Oct 20
521.24K
Avg daily vol (3M)
1.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| DEF 14A | — | 2021-04-28 | 2021-06-03 | |
| 8-K | — | 2021-03-12 | — | |
| 8-K | — | 2021-03-10 | 2021-03-09 | |
| 10-K | — | 2021-03-01 | 2020-12-31 | |
| 8-K | — | 2021-03-01 | 2021-02-23 | |
| 8-K | — | 2021-01-14 | 2021-01-12 | |
| 8-K/A | — | 2021-01-14 | 2020-11-03 | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | 2020-11-03 | |
| 8-K | — | 2020-08-17 | — | |
| 8-K | — | 2020-08-06 | — | |
| 10-Q | — | 2020-08-06 | 2020-06-30 | |
| 8-K | — | 2020-08-06 | — | |
| S-3 | — | 2020-06-03 | — | |
| 8-K | — | 2020-06-03 | 2020-06-01 | |
| 10-Q/A | — | 2020-05-26 | 2020-03-31 | |
| 10-Q/A | — | 2020-05-22 | 2020-03-31 | |
| 10-Q | — | 2020-05-21 | 2020-03-31 | |
| 8-K | — | 2020-05-21 | — | |
| 8-K | — | 2020-05-06 | — | |
| DEF 14A | — | 2020-04-28 | 2020-06-01 | |
| 8-K | — | 2020-03-13 | 2020-03-12 | |
| 8-K | — | 2020-03-11 | — | |
| 8-K | — | 2020-03-09 | 2019-12-31 | |
| 10-K | — | 2020-03-09 | 2019-12-31 | |
| 8-K | — | 2020-01-23 | — | |
| 8-K | — | 2020-01-13 | — | |
| 8-K | — | 2020-01-10 | 2020-01-08 |
Showing 101–128 of 128 filings
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
15 filings
15 filers
Visit website
Investor relations